Kris Hallenga, Who Urged Early Breast Cancer Screenings, Dies at 38
Kris Hallenga, Who Urged Early Breast Cancer Screenings, Dies at 38 The New York Times
sdgtalks
Article Summary
After being diagnosed when she was 23, she became determined to educate other young people about early detection.
When Kris Hallenga was diagnosed with Stage 4 breast cancer — the most advanced form — at 23, questions swirled through her head: “Why didn’t anyone tell me to check my boobs? Why didn’t I know I could get breast cancer at 23?”
If she hadn’t known that she could have breast cancer so young, there was a very good chance that others were equally uninformed, she said in a 2021 interview with The Guardian. She spent the next 15 years educating young people about early detection through her nonprofit organization, CoppaFeel, and in a 2021 memoir, “Glittering a Turd.”
On Monday, CoppaFeel announced that Ms. Hallenga had died at 38. A spokesman for the organization said she had died at home in Cornwall, England, and that the cause was breast cancer.
“Survival was never enough,” she said during a publicity tour in 2021. “I don’t just want to survive, I want to be able to really look at my life and go, ‘I’m glad to still be here, and I’m getting the most of what I want from life.’”
Kristen Hallenga was born on Nov. 11, 1985, in Norden, a small town in northern Germany, to a German father and an English mother, both of whom were teachers, according to The Times of London. When she was 9, she moved to Daventry in central England with her mother, Jane Hallenga; her twin sister, Maren Hallenga; and their older sister Maike Hallenga, all three of whom survive her. Her father, Reiner Hallenga, died of a heart attack when she was 20.
Ms. Hallenga first felt a lump in 2009 when she was in Beijing working for a travel company and teaching on the side. During a visit back home in the Midlands in central England, Ms. Hallenga went to her internist. She told The Guardian that her doctor had blamed the lump on hormonal changes associated with her birth control pill.
Introduction
Passing of Kris Hallenga
Background and Early Life
Diagnosis and Misinformation
SDGs, Targets, and Indicators
-
SDG 3: Good Health and Well-being
- Target 3.4: By 2030, reduce by one-third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being.
- Indicator 3.4.1: Mortality rate attributed to cardiovascular disease, cancer, diabetes, or chronic respiratory disease.
-
SDG 5: Gender Equality
- Target 5.6: Ensure universal access to sexual and reproductive health and reproductive rights as agreed in accordance with the Program of Action of the International Conference on Population and Development and the Beijing Platform for Action and the outcome documents of their review conferences.
- Indicator 5.6.1: Proportion of women aged 15-49 years who make their own informed decisions regarding sexual relations, contraceptive use, and reproductive health care.
Analysis
The article highlights the story of Kris Hallenga, who was diagnosed with Stage 4 breast cancer at a young age and dedicated her life to educating young people about early detection. Based on the content of the article, the following analysis can be made:
1. Which SDGs are addressed or connected to the issues highlighted in the article?
The issues highlighted in the article are connected to SDG 3: Good Health and Well-being and SDG 5: Gender Equality.
2. What specific targets under those SDGs can be identified based on the article’s content?
Based on the article’s content, the specific targets that can be identified are:
- Target 3.4: By 2030, reduce by one-third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being.
- Target 5.6: Ensure universal access to sexual and reproductive health and reproductive rights as agreed in accordance with the Program of Action of the International Conference on Population and Development and the Beijing Platform for Action and the outcome documents of their review conferences.
3. Are there any indicators mentioned or implied in the article that can be used to measure progress towards the identified targets?
The following indicators can be used to measure progress towards the identified targets:
- Indicator 3.4.1: Mortality rate attributed to cardiovascular disease, cancer, diabetes, or chronic respiratory disease.
- Indicator 5.6.1: Proportion of women aged 15-49 years who make their own informed decisions regarding sexual relations, contraceptive use, and reproductive health care.
Table: SDGs, Targets, and Indicators
| SDGs | Targets | Indicators |
|---|---|---|
| SDG 3: Good Health and Well-being | Target 3.4: By 2030, reduce by one-third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being. | Indicator 3.4.1: Mortality rate attributed to cardiovascular disease, cancer, diabetes, or chronic respiratory disease. |
| SDG 5: Gender Equality | Target 5.6: Ensure universal access to sexual and reproductive health and reproductive rights as agreed in accordance with the Program of Action of the International Conference on Population and Development and the Beijing Platform for Action and the outcome documents of their review conferences. | Indicator 5.6.1: Proportion of women aged 15-49 years who make their own informed decisions regarding sexual relations, contraceptive use, and reproductive health care. |
Copyright: Dive into this article, curated with care by SDG Investors Inc. Our advanced AI technology searches through vast amounts of data to spotlight how we are all moving forward with the Sustainable Development Goals. While we own the rights to this content, we invite you to share it to help spread knowledge and spark action on the SDGs.
Fuente: nytimes.com
Join us, as fellow seekers of change, on a transformative journey at https://sdgtalks.ai/welcome, where you can become a member and actively contribute to shaping a brighter future.
